Wennebergs oppgave 2013
Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation | NEJM
Årlig konferanse 2014 – Den Etiopisk Ortodoks Tewahedo Medhanealem Kirke
Wennebergs oppgave 2013
Pedi Kuns en Handwerk
King Bison | Facebook
Chemoprevention of Keratinocyte Carcinomas | SpringerLink
Årlig konferanse 2014 – Den Etiopisk Ortodoks Tewahedo Medhanealem Kirke
Årlig konferanse 2014 – Den Etiopisk Ortodoks Tewahedo Medhanealem Kirke
New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation - Waldner - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library
Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation | NEJM
![Cancer and mTOR inhibitors in kidney transplantation recipients [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2018/5864/1/fig-2-full.png "Cancer and mTOR inhibitors in kidney transplantation recipients [PeerJ]")
Cancer and mTOR inhibitors in kidney transplantation recipients [PeerJ]
High-Risk Cutaneous Squamous Cell Carcinoma
Early conversion to a CNI-free immunosuppression with SRL after renal transplantation—Long-term follow-up of a multicenter trial | PLOS ONE
PDF) Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months
Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
Wennebergs oppgave 2013
Årlig konferanse 2014 – Den Etiopisk Ortodoks Tewahedo Medhanealem Kirke
Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months | PLOS ONE
IJMS | Free Full-Text | Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?
![Cancer and mTOR inhibitors in kidney transplantation recipients [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2018/5864/1/fig-1-full.png "Cancer and mTOR inhibitors in kidney transplantation recipients [PeerJ]")
Cancer and mTOR inhibitors in kidney transplantation recipients [PeerJ]
![Cancer and mTOR inhibitors in kidney transplantation recipients [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2018/5864/1/fig-4-2x.jpg "Cancer and mTOR inhibitors in kidney transplantation recipients [PeerJ]")